Gainers
- Seres Therapeutics, Inc. MCRB rose 189% to $13.39 in pre-market trading after the company announced the results from its SER-109 Phase 3 ECOSPOR III study in recurrent C. difficile infection met the primary endpoint.
- Trevena, Inc. TRVN shares rose 79% to $4.26 in pre-market trading.
- Eton Pharmaceuticals, Inc. ETON rose 38.6% to $9.20 in pre-market trading. The FDA is said to rule on the NDA filed by Bausch Health Companies for EM-100, an investigational therapy for allergic conjunctivitis. The company had licensed this preservative-free ophthalmic solution from Eton Pharmaceuticals.
- TransAtlantic Petroleum Ltd. TAT rose 35.5% to $0.4597 in pre-market trading. On Friday, TransAtlantic Petroleum entered into an Agreement and Plan of Merger and a Loan and Security agreement.
- Highway Holdings Limited HIHO rose 25% to $3.74 in pre-market trading. Highway Holdings, earlier this month, announced a delay in reporting fiscal 2020 results due to coronavirus.
- OpGen, Inc. OPGN rose 23.8% to $4.17 in pre-market trading. OpGen said it is co-marketing COVID-19 antibody test kit offered by Menarini Silicon Biosystems.
- Usio, Inc USIO rose 22.5% to $3.48 in pre-market trading. Usio is expected to report Q2 results on August 14.
- Majesco MJCO rose 22.2% to $16.00 in pre-market trading after the company agreed to be acquired by Thoma Bravo. Majesco shareholders will receive $16 per share in cash.
- Marathon Patent Group, Inc. MARA rose 16.4% to $5.10 in pre-market trading after declining 14% on Friday.
- Ideanomics, Inc. IDEX shares rose 16% to $1.89 in pre-market trading.
- Hanco*ck Jaffe Laboratories, Inc. HJLI rose 15.8% to $0.42 in pre-market trading after jumping over 11% on Friday.
- Bridgeline Digital, Inc. BLIN rose 13% to $3.24 in pre-market trading.
- Hennessy Capital Acquisition Corp. IV HCAC rose 12.2% to $12.49 in pre-market trading.
- Inpixon INPX rose 12.2% to $1.56 in pre-market trading following report of FCC approval of the company's ultra-wideband module.
- Riot Blockchain, Inc. RIOT rose 11.4% to $4.20 in pre-market trading after dropping more than 11% on Friday.
- Document Security Systems, Inc. DSS rose 9.7% to $10.31 in pre-market trading after gaining over 7% on Friday.
- DouYu International Holdings Limited DOYU rose 9.4% to $16.70 in pre-market trading after the company reported Q2 results.
- Fennec Pharmaceuticals Inc. FENC rose 8.5% to $9.77 in pre-market trading ahead of expected FDA decision on pedmark for cisplatin-induced hearing loss.
- Willis Towers Watson Public Limited Company WLTW rose 7.2% to $213.82 in pre-market trading.
- Nxt-ID, Inc. NXTD rose 7% to $0.5875 in pre-market trading. Nxt-ID shares tumbled 20% on Friday after the company said it received determination letter from the Nasdaq stating the company has not regained compliance with $1 minimum bid price requirement.
- Lipocine Inc. LPCN rose 6% to $1.95 in pre-market trading. Lipocine, last week, reported a Q2 loss of $0.13 per share.
- Adamis Pharmaceuticals Corporation ADMP rose 6% to $1.25 in pre-market trading. Adamis Pharmaceuticals, last week, said it regained compliance with NASDAQ minimum bid price requirement.
- Verona Pharma plc VRNA rose 6% to $8.30 in pre-market trading after Canaccord Genuity initiated coverage on the company's stock with a Buy rating and announced a $17 price target.
- Twitter, Inc. TWTR rose 5.6% to $39.25 in pre-market trading. Twitter is in discussions with China’s ByteDance Ltd. for a potential merger with TikTok in the US, the Wall Street Journal reported.
- Schrodinger, Inc. SDGR rose 5.3% to $74.94 in pre-market trading after the company reported better-than-expected Q2 results.
- Information Services Group, Inc. III rose 3.3% to $2.19 in pre-market trading after the company reported better-than-expected Q2 results.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Eastman Kodak Company KODK fell 44.2% to $8.30 in pre-market trading. The federal government is halting a $765 million loan to Eastman Kodak for its generic drug-making foray until the company is cleared of insider trading allegations.
- Kazia Therapeutics Limited KZIA fell 14% to $5.51 in pre-market trading. Kazia Therapeutics shares surged over 50% on Friday after the FDA granted rare pediatric disease designation to paxalisib for Diffuse Intrinsic Pontine Glioma.
- iFresh Inc. IFMK fell 11.4% to $0.9655 in pre-market trading. IFresh, on Friday, entered into a deal with shareholders Zhang Fei, Liu Meng, Jiuxiang Blue Sky to sell 100% interest in Jiuxiang Blue Sky for ~5.04m shares of its common stock.
- Zion Oil & Gas, Inc. ZN fell 10.4% to $0.38 in pre-market trading.
- Actinium Pharmaceuticals, Inc. ATNM fell 9.5% to $0.3849 in pre-market trading after the company reported a $500 million mixed securities offering on Friday.
- Natera, Inc. NTRA fell 8.5% to $48.40 in pre-market trading. Natera, on Friday, filed additional suit against ArcherDX for patent infringement.
- Ambow Education Holding Ltd. AMBO shares fell 8.3% to $2.79 in pre-market trading. Ambow Education shares gained 13% on Friday after the company announced the launch of Huanyujun Education Hub, a next-generation online-to-offline education SaaS platform.
- ADiTx Therapeutics, Inc. ADTX fell 7.6% to $5.40 in pre-market trading after declining 23% on Friday. ADiTx Therapeutics, last week, reported introduction of AditxtScore for COVID-19 and announced completion of validation studies by Stanford Blood Center.
- Whiting Petroleum Corporation WLL fell 7% to $0.84 in pre-market trading.
- Innovative Solutions and Support, Inc. ISSC fell 7% to $6.25 in pre-market trading after jumping over 12% on Friday. Innovative Solutions and Support released upbeat earnings last week.
- American Virtual Cloud Technologies, Inc. AVCT fell 6.8% to $7.31 in pre-market trading. American Virtual Cloud Technologies, last week, announced plans to buy Ribbon's Kandy Communications Business.
- Eros International Plc EROS fell 5.6% to $2.51 in pre-market trading after gaining over 7% on Friday.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
